ARCHIVES

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

More Clinical Trials Money Top Priority, DeVita Says; Drug Discovery Groups RFA Gets 12 Applications

February 24, 1984

ACCC Members Find Few Answers, Many Problems

February 7, 1975

Karlan To Succeed Hoskins As Chairman, DOD Ovarian Cancer Program Advisory Panel.

July 27, 2001

Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.”

March 9, 2007

Mesothelioma Survival, QOL Improved With Alimta, Platinol

March 28, 2003

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003